97151-02-5,MFCD02101152
Catalog No.:AA01CBQ6

97151-02-5 | Benzeneethanol,b-[[4-[2-(dimethylamino)ethoxy]phenyl]phenylmethylene]-a-methyl-,(bE)-

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
≥98%
in stock  
$82.00   $57.00
- +
5mg
≥98%
in stock  
$306.00   $214.00
- +
10mg
≥98%
in stock  
$479.00   $335.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA01CBQ6
Chemical Name:
Benzeneethanol,b-[[4-[2-(dimethylamino)ethoxy]phenyl]phenylmethylene]-a-methyl-,(bE)-
CAS Number:
97151-02-5
Molecular Formula:
C26H29NO2
Molecular Weight:
387.5140
MDL Number:
MFCD02101152
SMILES:
CC(C(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3)O
Properties
Computed Properties
 
Complexity:
495  
Covalently-Bonded Unit Count:
1  
Defined Bond Stereocenter Count:
1  
Heavy Atom Count:
29  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
8  
Undefined Atom Stereocenter Count:
1  
XLogP3:
5.9  

Literature

Title: Assessment of the impact of CYP3A polymorphisms on the formation of α-hydroxytamoxifen and N-desmethyltamoxifen in human liver microsomes.

Journal: Drug metabolism and disposition: the biological fate of chemicals 20120201

Title: Effect of N,N-didesmethyltamoxifen upon DNA adduct formation by tamoxifen and alpha-hydroxytamoxifen.

Journal: Cancer letters 20071118

Title: Formation of tamoxifen-DNA adducts via O-sulfonation, not O-acetylation, of alpha-hydroxytamoxifen in rat and human livers.

Journal: Drug metabolism and disposition: the biological fate of chemicals 20051101

Title: Tamoxifen-DNA adduct formation in human endometrium.

Journal: Chemical research in toxicology 20051001

Title: Characterization of the human cytochrome P450 forms involved in metabolism of tamoxifen to its alpha-hydroxy and alpha,4-dihydroxy derivatives.

Journal: Chemical research in toxicology 20051001

Title: Organ specificity of DNA adduct formation by tamoxifen and alpha-hydroxytamoxifen in the rat: implications for understanding the mechanism(s) of tamoxifen carcinogenicity and for human risk assessment.

Journal: Mutagenesis 20050701

Title: Formation of tamoxifen-DNA adducts in human endometrial explants exposed to alpha-hydroxytamoxifen.

Journal: Chemical research in toxicology 20050501

Title: UDP-glucuronosyltransferases and clinical drug-drug interactions.

Journal: Pharmacology & therapeutics 20050401

Title: Interactions of the stereoisomers of alpha-hydroxytamoxifen with human hydroxysteroid sulfotransferase SULT2A1 and rat hydroxysteroid sulfotransferase STa.

Journal: Drug metabolism and disposition: the biological fate of chemicals 20041201

Title: Stereoselective metabolic activation of alpha-hydroxy-N-desmethyltamoxifen: the R-isomer forms more DNA adducts in rat liver cells.

Journal: Chemical research in toxicology 20040501

Title: Biotransformation of tamoxifen in a human endometrial explant culture model.

Journal: Chemico-biological interactions 20031215

Title: Alpha-hydroxylation of tamoxifen and toremifene by human and rat cytochrome P450 3A subfamily enzymes.

Journal: Chemical research in toxicology 20030901

Title: Identification of human CYP forms involved in the activation of tamoxifen and irreversible binding to DNA.

Journal: Carcinogenesis 20021101

Title: The mutational signature of alpha-hydroxytamoxifen at Hprt locus in Chinese hamster cells.

Journal: Carcinogenesis 20021101

Title: Mutations induced by alpha-hydroxytamoxifen in the lacI and cII genes of Big Blue transgenic rats.

Journal: Carcinogenesis 20021001

Title: Induction of lacI mutations in Big Blue rats treated with tamoxifen and alpha-hydroxytamoxifen.

Journal: Cancer letters 20020208

Title: Resolution of alpha-hydroxytamoxifen; R-isomer forms more DNA adducts in rat liver cells.

Journal: Chemical research in toxicology 20010701

Title: Short-term dosing of alpha-hydroxytamoxifen results in DNA damage but does not lead to liver tumours in female Wistar/Han rats.

Journal: Carcinogenesis 20010401

Title: Phillips DH, et al. alpha-Hydroxytamoxifen, a metabolite of tamoxifen with exceptionally high DNA-binding activity in rat hepatocytes. Cancer Res. 1994 Nov 1;54(21):5518-22.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:97151-02-5 Molecular Formula|97151-02-5 MDL|97151-02-5 SMILES|97151-02-5 Benzeneethanol,b-[[4-[2-(dimethylamino)ethoxy]phenyl]phenylmethylene]-a-methyl-,(bE)-
Catalog No.: AA01CBQ6
97151-02-5,MFCD02101152
97151-02-5 | Benzeneethanol,b-[[4-[2-(dimethylamino)ethoxy]phenyl]phenylmethylene]-a-methyl-,(bE)-
Pack Size: 1mg
Purity: ≥98%
in stock
$82.00 $57.00
Pack Size: 5mg
Purity: ≥98%
in stock
$306.00 $214.00
Pack Size: 10mg
Purity: ≥98%
in stock
$479.00 $335.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA01CBQ6
Chemical Name: Benzeneethanol,b-[[4-[2-(dimethylamino)ethoxy]phenyl]phenylmethylene]-a-methyl-,(bE)-
CAS Number: 97151-02-5
Molecular Formula: C26H29NO2
Molecular Weight: 387.5140
MDL Number: MFCD02101152
SMILES: CC(C(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3)O
Properties
Complexity: 495  
Covalently-Bonded Unit Count: 1  
Defined Bond Stereocenter Count: 1  
Heavy Atom Count: 29  
Hydrogen Bond Acceptor Count: 3  
Hydrogen Bond Donor Count: 1  
Rotatable Bond Count: 8  
Undefined Atom Stereocenter Count: 1  
XLogP3: 5.9  
Literature fold

Title: Assessment of the impact of CYP3A polymorphisms on the formation of α-hydroxytamoxifen and N-desmethyltamoxifen in human liver microsomes.

Journal: Drug metabolism and disposition: the biological fate of chemicals20120201

Title: Effect of N,N-didesmethyltamoxifen upon DNA adduct formation by tamoxifen and alpha-hydroxytamoxifen.

Journal: Cancer letters20071118

Title: Formation of tamoxifen-DNA adducts via O-sulfonation, not O-acetylation, of alpha-hydroxytamoxifen in rat and human livers.

Journal: Drug metabolism and disposition: the biological fate of chemicals20051101

Title: Tamoxifen-DNA adduct formation in human endometrium.

Journal: Chemical research in toxicology20051001

Title: Characterization of the human cytochrome P450 forms involved in metabolism of tamoxifen to its alpha-hydroxy and alpha,4-dihydroxy derivatives.

Journal: Chemical research in toxicology20051001

Title: Organ specificity of DNA adduct formation by tamoxifen and alpha-hydroxytamoxifen in the rat: implications for understanding the mechanism(s) of tamoxifen carcinogenicity and for human risk assessment.

Journal: Mutagenesis20050701

Title: Formation of tamoxifen-DNA adducts in human endometrial explants exposed to alpha-hydroxytamoxifen.

Journal: Chemical research in toxicology20050501

Title: UDP-glucuronosyltransferases and clinical drug-drug interactions.

Journal: Pharmacology & therapeutics20050401

Title: Interactions of the stereoisomers of alpha-hydroxytamoxifen with human hydroxysteroid sulfotransferase SULT2A1 and rat hydroxysteroid sulfotransferase STa.

Journal: Drug metabolism and disposition: the biological fate of chemicals20041201

Title: Stereoselective metabolic activation of alpha-hydroxy-N-desmethyltamoxifen: the R-isomer forms more DNA adducts in rat liver cells.

Journal: Chemical research in toxicology20040501

Title: Biotransformation of tamoxifen in a human endometrial explant culture model.

Journal: Chemico-biological interactions20031215

Title: Alpha-hydroxylation of tamoxifen and toremifene by human and rat cytochrome P450 3A subfamily enzymes.

Journal: Chemical research in toxicology20030901

Title: Identification of human CYP forms involved in the activation of tamoxifen and irreversible binding to DNA.

Journal: Carcinogenesis20021101

Title: The mutational signature of alpha-hydroxytamoxifen at Hprt locus in Chinese hamster cells.

Journal: Carcinogenesis20021101

Title: Mutations induced by alpha-hydroxytamoxifen in the lacI and cII genes of Big Blue transgenic rats.

Journal: Carcinogenesis20021001

Title: Induction of lacI mutations in Big Blue rats treated with tamoxifen and alpha-hydroxytamoxifen.

Journal: Cancer letters20020208

Title: Resolution of alpha-hydroxytamoxifen; R-isomer forms more DNA adducts in rat liver cells.

Journal: Chemical research in toxicology20010701

Title: Short-term dosing of alpha-hydroxytamoxifen results in DNA damage but does not lead to liver tumours in female Wistar/Han rats.

Journal: Carcinogenesis20010401

Title: Phillips DH, et al. alpha-Hydroxytamoxifen, a metabolite of tamoxifen with exceptionally high DNA-binding activity in rat hepatocytes. Cancer Res. 1994 Nov 1;54(21):5518-22.

Building Blocks More >
60696-39-1
60696-39-1
Benzene-2,3,6-d3-acetic-a,a-d2 acid, 4,5-dihydroxy-
AA01CBTN | MFCD00209710
2088449-88-9
2088449-88-9
Isopropyl 5-(Diphenylphosphoryl)pentanoate
AA01CBWC
950912-80-8
950912-80-8
PF-670462
AA01CC00 | MFCD12828759
1217675-13-2
1217675-13-2
Lubiprostone-d7
AA01CC36
55814-41-0
55814-41-0
Benzamide, 2-methyl-N-[3-(1-methylethoxy)phenyl]-
AA01CC68 | MFCD00144739
1219151-49-1
1219151-49-1
4-Methylbenzotriazole-d3
AA01CC9J | MFCD28138661
194930-04-6
194930-04-6
Carbamic acid, ethylmethyl-, 3-[1-[di(methyl-d3)amino]ethyl]phenyl ester
AA01CCCR | MFCD09841252
1246820-85-8
1246820-85-8
Sotalol-d6 Hydrochloride
AA01CCG9 | MFCD04972578
1622206-36-3
1622206-36-3
1-Thio-β-D-glucose Sodium Salt Dihydrate
AA01CCJN | MFCD30749324
1778734-73-8
1778734-73-8
α-Zearalenol-d4 (Major)
AA01CCNW
Submit
© 2017 AA BLOCKS, INC. All rights reserved.